THE MANAGEMENT OF ISOLATED RENAL RECURRENCE OF RENAL-CELL CARCINOMA FOLLOWING COMPLETE RESPONSE TO INTERLEUKIN-2 BASED IMMUNOTHERAPY

被引：12
作者：
LONG, JP [1 ]
WALTHER, MM [1 ]
ALEXANDER, RB [1 ]
LINEHAN, WM [1 ]
ROSENBERG, SA [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,SURG BRANCH,BETHESDA,MD 20892
来源：
JOURNAL OF UROLOGY | 1993年 / 150卷 / 01期
关键词：
CARCINOMA; RENAL CELL; KIDNEY NEOPLASMS; NEOPLASM METASTASIS; INTERLEUKIN-2; IMMUNOTHERAPY;
D O I：
10.1016/S0022-5347(17)35428-9
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The role of interleukin-2 based immunotherapy in advanced renal cell carcinoma is gradually expanding. Among patients who achieve significant responses to these regimens the subsequent development of isolated recurrences raises difficult management questions. We report 2 unusual cases of isolated recurrence in the remaining kidney following a sustained, complete response to interleukin-2 based adoptive immunotherapy. Both patients were treated with interleukin-2 based therapy following surgical resection of the primary renal tumor. The disease course of each patient is described and the literature is reviewed. Both patients were free of disease after relatively short-term followup. Surgery for patients with limited recurrence of renal cell carcinoma following an objective response to immunotherapy may, in select cases, be a reasonable treatment alternative.
引用
收藏
页码：176 / 178
页数：3
相关论文
共 23 条
  • [11] CONSERVATIVE SURGERY OF RENAL-CARCINOMA - THE EIRSS EXPERIENCE
    MARBERGER, M
    PUGH, RCB
    AUVERT, J
    BERTERMANN, H
    COSTANTINI, A
    GAMMELGAARD, PA
    PETTERSON, S
    WICKHAM, JEA
    [J]. BRITISH JOURNAL OF UROLOGY, 1981, 53 (06): : 528 - 532
  • [12] CONSERVATIVE SURGERY FOR RENAL-CELL CARCINOMA - A SINGLE-CENTER EXPERIENCE WITH 100 PATIENTS
    NOVICK, AC
    STREEM, S
    MONTIE, JE
    PONTES, JE
    SIEGEL, S
    MONTAGUE, DK
    GOORMASTIC, M
    [J]. JOURNAL OF UROLOGY, 1989, 141 (04) : 835 - 839
  • [13] RENAL-CELL CARCINOMA - RESECTION OF SOLITARY AND MULTIPLE METASTASES
    POGREBNIAK, HW
    HAAS, G
    LINEHAN, WM
    ROSENBERG, SA
    PASS, HI
    PUTNAM, JB
    MANSOUR, KA
    COOK, WA
    [J]. ANNALS OF THORACIC SURGERY, 1992, 54 (01) : 33 - 38
  • [14] PRESTI JC, 1991, CANCER RES, V51, P1544
  • [15] ROBBINS SL, 1979, PATHOLOGIC BASIS DIS, P1181
  • [16] A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE
    ROSENBERG, SA
    LOTZE, MT
    MUUL, LM
    CHANG, AE
    AVIS, FP
    LEITMAN, S
    LINEHAN, WM
    ROBERTSON, CN
    LEE, RE
    RUBIN, JT
    SEIPP, CA
    SIMPSON, CG
    WHITE, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) : 889 - 897
  • [17] COMBINATION THERAPY WITH INTERLEUKIN-2 AND ALPHA-INTERFERON FOR THE TREATMENT OF PATIENTS WITH ADVANCED CANCER
    ROSENBERG, SA
    LOTZE, MT
    YANG, JC
    LINEHAN, WM
    SEIPP, C
    CALABRO, S
    KARP, SE
    SHERRY, RM
    STEINBERG, S
    WHITE, DE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) : 1863 - 1874
  • [18] EXPERIENCE WITH THE USE OF HIGH-DOSE INTERLEUKIN-2 IN THE TREATMENT OF 652 CANCER-PATIENTS
    ROSENBERG, SA
    LOTZE, MT
    YANG, JC
    AEBERSOLD, PM
    LINEHAN, WM
    SEIPP, CA
    WHITE, DE
    [J]. ANNALS OF SURGERY, 1989, 210 (04) : 474 - 485
  • [19] SHERRY RM, 1992, CANCER, V69, P1850, DOI 10.1002/1097-0142(19920401)69:7<1850::AID-CNCR2820690729>3.0.CO
  • [20] 2-I
123